--2025/Q2-- / 1.286M--
--2025/Q1-- / 786.100K--
Mar 5, 20252024/Q430.604M / 37.171M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
ASML Holding
ASML
Disney
DIS
Apple
AAPL
Salesforce
CRM
Cisco
CSCO
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.315
- -0.095-6.74%
Close Mar 18 16:00 ET
- 1.329
- +0.014+1.09%
Post 17:08 ET
109.11MMarket Cap-0.46P/E (TTM)
1.440High1.310Low1.53MVolume1.410Open1.410Pre Close2.06MTurnover1.86%Turnover RatioLossP/E (Static)82.98MShares7.59552wk High0.81P/B108.65MFloat Cap1.12052wk Low--Dividend TTM82.62MShs Float99.950Historical High--Div YieldTTM9.22%Amplitude1.120Historical Low1.343Avg Price1Lot Size
Editas Medicine Key Stats
Editas Medicine Q4 2024 Earnings Date
Currency：USDMar 5, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 37.17M | 30.60M | -6.57M |
| Miss Est. | -38.10% | -49.03% | -17.67% |
| EPS | -0.35 | -0.55 | -0.20 |
| Miss Est. | -52.50% | -139.13% | -56.87% |
Analyst Rating
Mar 18, 2025
Editas Medicine Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Editas Medicine Earnings Reports
Read more
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
